Lazard, Inc. filings document the regulatory record for a financial advisory and asset management company listed on the NYSE under LAZ. Form 8-K reports furnish quarterly and annual results, Regulation FD strategy updates, material agreements, executive officer changes, compensation arrangements, and other material-event disclosures tied to the firm’s advisory and asset management businesses.
Proxy materials cover board elections, governance practices, executive compensation and shareholder voting matters. The company’s risk-factor disclosures address conditions in global and regional financial markets, M&A activity, assets under management, liquidity, third-party exposures and competition, alongside capital-structure and reporting matters.
Lazard, Inc. (LAZ) received an amended Schedule 13G/A from BlackRock, Inc., which reports beneficial ownership of 10,871,335 shares of Lazard common stock, representing 11.2% of the class.
BlackRock has sole voting power over 10,626,033 shares and sole dispositive power over 10,871,335 shares, with no shared voting or dispositive power. The filing covers specific BlackRock business units, and various underlying clients have economic rights, but no one client holds more than five percent of Lazard’s outstanding common shares.
Lazard, Inc. (LAZ) received a notice that former board member Andrew Alper plans to sell up to 10,000 common shares of Lazard under Rule 144 through Goldman Sachs & Co. LLC as broker. The shares were acquired on 07/28/2026 as compensation via Restricted Stock Awards, and follow prior sales in the last three months.
Lazard, Inc. (LAZ) reported that CEO & Chairman Peter Richard Orszag executed a series of equity transactions involving Common Stock and derivative awards. On August 24, 2026, he exercised 250,000 Stock Price Profits Interest Participation Rights (SP-PIPRs), receiving 250,000 shares of Common Stock, and disposed of 75,000 shares back to the company to cover estimated taxes from that exchange. On August 25, 2026, he sold 125,000 shares of Common Stock at a weighted average price of $43.5203 per share under a Rule 10b5-1 trading plan adopted on March 13, 2025, with sales intended to cover estimated taxes and other personal expenditures. Following the derivative exercise, 1,000,000 SP-PIPRs remain outstanding, including 500,000 scheduled to vest on or around August 23, 2028, and 500,000 scheduled to vest on or around August 23, 2030, subject to continued service and, for the latter, a stock price milestone.
Lazard, Inc. (LAZ) has a notice of proposed sale under Rule 144 for common stock held for the account of Peter Richard Orszag. The filing indicates an intention to sell 125,000 shares of Lazard common stock through Fidelity Brokerage Services LLC, with an aggregate market value of $5,440,042.97, based on 110,548,172 shares outstanding and an approximate sale date of August 25, 2026. The shares are to come from restricted stock vesting on August 23, 2026, received from the issuer as compensation.
Lazard, Inc. (LAZ) is the issuer of common shares that former board member Andrew Alper has notified for potential sale under Rule 144. The notice covers 10,000 common shares, to be sold through Goldman Sachs & Co. LLC on the NYSE, with an indicated aggregate market value of 427700 as of 08/20/2026.
The shares were acquired from the issuer on 07/28/2026 as compensation in the form of Restricted Stock Awards. No sales of these securities are listed as having occurred during the prior three months.
Lazard, Inc. (LAZ) reported that director Stephen R. Howe Jr., as the reporting person, received a grant of 103 Deferred Stock Units (DSUs) under Lazard, Inc.'s 2018 Incentive Compensation Plan. These DSUs, elected in lieu of cash director compensation, will convert into an equal number of shares of Common Stock on a one-for-one basis when he ceases to serve on the Board, bringing his directly held DSU balance to 14,843 units.
Lazard, Inc. (LAZ) reported that Chief Accounting Officer Michael Gathy received an award of 145 Restricted Stock Units (RSUs), acquired through dividend equivalent reinvestment on existing RSU awards. Each RSU represents a contingent right to receive one share of Common Stock. Following this award, Gathy holds 13,037 RSUs, which will vest over time, and this figure excludes 1,438 shares of Common Stock that are directly or indirectly beneficially owned.
Lazard, Inc. (LAZ) reported that Christopher Hogbin, CEO of Asset Management, acquired 2,954 Restricted Stock Units (RSUs) linked to Lazard common stock. The RSUs arose from dividend equivalent reinvestment on existing RSU awards. Of these RSUs, 985 will vest on or around March 18, 2027, 985 on or around March 20, 2028, and 984 on or around March 22, 2029. Following this grant, Hogbin directly held 266,659 RSUs, which are separate from 11,829 shares of common stock that he also beneficially owns directly or indirectly.
Lazard, Inc. (LAZ) reported that Chief Operating Officer Alexandra Soto acquired 3,413 Restricted Stock Units (RSUs), treated as a grant or award tied to Lazard common stock. Each RSU represents a contingent right to receive one share of common stock if and when it vests.
The RSUs include amounts acquired through dividend equivalent reinvestment on existing RSU awards. Of this grant, 1,087 RSUs are scheduled to vest on or around March 1, 2027, 1,174 RSUs on or around March 1, 2028, and 1,152 RSUs on or around March 1, 2029. After this transaction, Soto directly holds 308,034 RSUs, excluding 148,185 shares of Lazard common stock that are directly or indirectly beneficially owned outside these RSUs.
Lazard, Inc. (LAZ) reported that Chief Financial Officer Tracy Farr acquired 426 Restricted Stock Units (RSUs) as a grant/award tied to dividend equivalent reinvestment. Each RSU represents a contingent right to receive one share of Common Stock. Of these RSUs, 233 vest on or around March 1, 2027, 146 vest on or around March 1, 2028, and 47 vest on or around March 1, 2029. Following this award, Farr holds 38,395 RSUs, excluding 2,889 shares of Common Stock separately beneficially owned.